0001209191-21-033399.txt : 20210518
0001209191-21-033399.hdr.sgml : 20210518
20210518113511
ACCESSION NUMBER: 0001209191-21-033399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210517
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Jason Drew
CENTRAL INDEX KEY: 0001821479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 21934866
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-17
0
0001668243
UroGen Pharma Ltd.
URGN
0001821479
Smith Jason Drew
C/O UROGEN PHARMA LTD.
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
0
1
0
0
General Counsel
Common Stock
2021-05-17
4
P
0
2500
15.71
A
2500
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675
and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ Jason D. Smith
2021-05-17